Heart warning added to diabetes drug Avandia

Nov14, 2007 CNN carried this story...read the full story by clicking the title link.

WASHINGTON (AP) -- The US FDA warned that a popular diabetes drug Avandia may, or may not, increase the risk of heart attacks.

Glaxo - the drug manufacturer agreed to FDA's demand for a major study directly comparing Avandia and its competitors' heart effects. The study will begin by next November and won't end until 2014, but the FDA will order interim checks to see how patients are faring and if it's possible to settle the issue any sooner. Can you take the risk and wait for the results?

In contrast, Health Canada announced that Avandia should be used only in combination with certain other drugs for hard-to-control blood sugar.

Dr. Steven Nissen of the Cleveland Clinic, who first brought the heart attack issue to public attention, said that he preferred Canada's approach -- but that Wednesday's warning is important and timely.

Last May, a 6 month study of 10,000 patients was published showing Avandia users had a 43% greater chance of getting a heart attack, than those not using this drug. Does this scare you?

About 1 million Americans with Type 2 diabetes use Avandia. It helps control blood sugar by increasing the body's sensitivity to insulin.

Bioslife can help those with high blood sugar, from starting on these life threatening drugs and also help current diabetics reduce their dependance on diabetes drugs within 3-12 months.